Novocure Ltd Equity-NMS: NVCR

Healthcare

Medical Instruments & Supplies

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$81.54
Today's high :$82.05
Today's low :$79.87
52W low :$56.39
52W high :$94
1Y :-28.89%
5Y :345.13%
EPS(TTM): :-0.7825
Shares O/S :104.95 M
Market cap :8.4 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Novocure Ltd today?

Novocure Ltd (NVCR) share price as of October 11, 2022, is $79.12. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Novocure Ltd?

Yes, Indian Investors can invest in the Novocure Ltd (NVCR) Share by opening an international trading account with Angel One.

How can I purchase Novocure Ltd shares in India?

Purchasing Novocure Ltd (NVCR) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Novocure Ltd (NVCR) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Novocure Ltd?

Yes, you can purchase fractional shares of Novocure Ltd (NVCR) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Novocure Ltd?

The market capitalization of Novocure Ltd on December 3, 2022, is $8.29 B.

In which sector Novocure Ltd belongs?

Novocure Ltd operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.

What documents are required to invest in Novocure Ltd stocks?

In order to invest in Novocure Ltd (NVCR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Novocure Ltd

NovoCure Limited is an oncology company. The Company is principally engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua, for the treatment of solid tumor cancers. TTFields therapy is a treatment that uses electric fields tuned to specific frequencies to disrupt cancer cell division. TTFields therapy is delivered through a portable medical device. Optune is approved by the United States Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed glioblastoma (GBM) together with temozolomide, a chemotherapy drug, and for adult patients with GBM following confirmed recurrence after chemotherapy as monotherapy treatment. Optune Lua is approved by the FDA for the pathway for the treatment of malignant pleural mesothelioma (MPM) together with standard chemotherapies. It markets its products to United States, European Union, Germany, Japan and certain other countries.